Defective calcium homeostasis in the cerebellum in a mouse model of Niemann-Pick a disease

Journal of Neurochemistry

Volumn 95, Issue 6, 2005, Pages 1619-1628

  Ginzburg, Luba ^a   Futerman, Anthony H ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Calcium; Cerebellum; Degeneration; Niemann Pick; Sphingomyelin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CALCIUM CHANNEL; FRUCTOSE BISPHOSPHATE ALDOLASE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; RYANODINE RECEPTOR; SPHINGOMYELIN PHOSPHODIESTERASE; UNCLASSIFIED DRUG; ZEBRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CELL DEGENERATION; CEREBELLUM; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; LIPIDOSIS; MOUSE; NEUROPATHOLOGY; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE CELL; SANDHOFF DISEASE; SARCOPLASMIC RETICULUM;

AGING; ANIMALS; BLOTTING, WESTERN; CALCIUM; CALCIUM-TRANSPORTING ATPASES; CEREBELLUM; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENT ANTIBODY TECHNIQUE; HOMEOSTASIS; HUMANS; MICE; MICE, KNOCKOUT; MICROSOMES; NERVE TISSUE PROTEINS; NIEMANN-PICK DISEASES; PURKINJE CELLS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SPHINGOMYELIN PHOSPHODIESTERASE; TISSUE FIXATION;

ANIMALIA;

EID: 29144444023     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03534.x     Document Type: Article

References (36)

1. Baron C. B., Ozaki S., Watanabe Y., Hirata M., LaBelle E. F. and Coburn R. F. (1995) Inositol 1,4,5-trisphosphate binding to porcine tracheal smooth muscle aldolase. J. Biol. Chem. 270, 20 459-20 465.
2. Berridge M. J., Bootman M. D. and Roderick H. L. (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4, 517-529.
3. Bligh E. G. and Dyer W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911-917.
4. Brunngraber E. G., Berra B. and Zambotti V. (1973) Altered levels of tissue glycoprqteins, gangliosides, glycosaminoglycans and lipids in Niemann-Pick's disease. Clin. Chim. Acta 48, 173-181.
5. Buccoltero R., Bodennec J., van Echten-Deckert G., Sandhoff K. and Futerman A. H. (2004a) Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease. J. Neurochem. 90, 80-88.
6. Buccoliero R., Ginzburg L. and Futerman A. H. (2004b) Elevation of lung surfactant phosphatidylcholine in mouse models of Sandhoff and of Niemann-Pick A disease. J. Inherit. Metab. Dis. 27, 641-648.
7. De Camilli P., Miller P. E., Levitt P., Walter U. and Greengard P. (1984) Anatomy of cerebellar Purkinje cells in the rat determined by a specific immunohistochemical marker. Neuroscience 11, 761-817.
8. Futerman A. H. and van Meer G. (2004) The cell biology of lysosomal storage disease. Nat. Rev. Mol. Cell Biol. 5, 554-565.
9. Ghosh T. K., Eis P. S., Mullaney J. M., Ebert C. L. and Gill D. L. (1988) Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate- activated calcium release by heparin. J. Biol Chem. 263, 11 075-11 079.
10. Ginzburg L., Kacher Y. and Futerman A. H. (2004) The pathogenesis of glycosphingolipid storage disorders. Semin. Cell Dev. Biol. 15, 417-431.
11. Hawkes R. and Herrup K. (1995) Aldolase C/zebrin II and the regionalization of the cerebellum. J. Mol. Neurosci. 6, 147-158.
12. Hirota J., Ando H., Hamada K. and Mikoshiba K. (2003) Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1. Biochem. J. 372, 435-441.
13. Horinouchi K., Erlich S., Perl D. P., Ferlinz K., Bisgaier C. L., Sandhoff K., Desnick R. J., Stewart C. L. and Schuchman E. H. (1995) Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Genet. 10, 288-293.
14. Korkotian E., Schwarz A., Pelled D., Schwarzmann G., Segal M. and Futerman A. H. (1999) Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 274, 21 673-21 678.
15. Lin X., Antalffy B., Kang D., Orr H. T. and Zoghbi H. Y. (2000) Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci. 3, 157-163.
16. Lloyd-Evans E., Pelled D., Riebeling C, Bodennec J., de-Morgan A., Waller H., Schiffmann R. and Futerman A. H. (2003a) Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J. Biol. Chem. 278, 23 594-23 599.
17. Lloyd-Evans E., Pelled D., Riebeling C. and Futerman A. H. (2003b) Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms. Biochem. J. 375, 561-565.
18. Mattson M. P. and Chan S. L. (2003) Calcium orchestrates apoptosis. Nat. Cell Biol. 5, 1041-1043.
19. 2+ stores: ubiquitous partners of surface channels in neurons. News Physiol. Sci. 17, 144-149.
20. Meyer zu Heringdorf D., Himmel H. M. and Jakobs K. H. (2002) Sphingosylphosphorylcholine-biological functions and mechanisms of action. Biochim. Biophys. Acta 1582, 178-189.
21. 2+ signaling and calcium binding chaperones of the endoplasmic reticulum. Cell Calcium 32, 269-278.
22. Pelled D., Lloyd-Evans E., Riebeling C., Jeyakumar M., Platt F. M. and Futerman A. H. (2003) Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca -ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin. J. Biol. Chem. 278, 29496-29501.
23. Pelled D., Trajkovic-Bodennec S., Lloyd-Evans E., Sidransky E., Schiffmann R. and Futerman A. H. (2005) Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol. Dis. 18, 83-88.
24. Raas-Rothschild A., Pankova-Kholmyansky I., Kacher Y. and Futerman A. H. (2004) Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj. J. 21, 295-304.
25. Rodriguez-Lafrasse C. and Vanier M. T. (1999) Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B. Neurochem. Res. 24, 199-205.
26. Sarna J. R. and Hawkes R. (2003) Patterned Purkinje cell death in the cerebellum. Prog. Neurobiol 70, 473-507.
27. Sarna J., Miranda S. R., Schuchman E. H. and Hawkes R. (2001) Patterned cerebellar Purkinje cell death in a transgenic mouse model of Niemann Pick type A/B disease. Eur. J. Neurosci. 13, 1873-1880.
28. Schuchman E. H. and Desnick R. J. (2001) Niemann-Pick disease types A and B: acid sphingomyelinase deficiences, in The Metabolic and Molecular Bases of Inherited Disease, Vol. II (Scriver C. R., Sly W. S., Childs B., Beaudet A. L., Valle D., Kinzler K. W. and Vogelstein B., eds), pp. 3589-3605. McGraw-Hill Inc., Columbus, USA.
29. Serra H. G., Byam C. E., Lande J. D., Tousey S. K., Zoghbi H. Y. and Orr H. T. (2004) Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum. Mol. Genet. 13, 2535-2543.
30. Tessitore A. M., Del P. Martin, Sano R., Ma Y., Mann L., Ingrassia A., Laywell E. D., Steindler D. A., Hendershot L. M. and d'Azzo A. (2004) GM1-ganglioside-mediated activation of the unfolded protein response causes neuronal death in a neurodegenerative gangliosidosis. Mol. Cell 15, 753-766.
31. 2--ATPases. Trends Pharmacol. Sci. 19, 131-135.
32. Vig P. J., Subramony S. H., Burright E. N., Fratkin J. D., McDaniel D. O., Desaiah D. and Qin Z. (1998) Reduced immunoreactivity to calcium binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology 50, 106-113.
33. 2+ ATPase and of the ER luminal protein, Bip. J. Cell Biol. 113, 779-791.
34. 2+ protects against thapsigargin inhibition in neuronal endoplasmic reticulum. J. Biol. Chem. 273, 5020-5025.
35. Wenger D. A., Sattler M., Kudoh T., Snyder S. P. and Kingston R. S. (1980) Niemann-Pick disease: a genetic model in Siamese cats. Science 208, 1471-1473.
36. 2+-ATPase isoform transcripts. Am. J. Physiol. 269, C775-C784.